Massachusetts drug maker Pfizer could receive 100 million doses of ‘most advanced’ coronavirus vaccine this year


The company behind the “most advanced” coronavirus vaccine in development said it could produce 100 million doses by the end of the year and up to 1.3 billion by 2021 at a key facility here in Massachusetts.

“As we continue to fight this virus, against COVID-19, a vaccine and treatment cannot come soon enough. Pfizer is developing one of the most advanced COVID-19 vaccines, ”said Governor Charlie Baker during a tour of the Pfizer facility in Andover on Thursday.

The Pfizer vaccine uses mRNA to deliver genetic instructions to cells, in this case the SARS COVI protein, which should then elicit an immune response, Pfizer vice president of global research and development Dr. Meg Ruesch explained Thursday.

The investigation into the Pfizer mRNA vaccine candidate began in March, he said.

“Our ability to manufacture quality and speed mRNA at Pfizer Andover is due to the outstanding scientists, engineers, and support staff we have here. In the fight against this global pandemic, we really believe that science will win, “said Reusch.

Messenger ribonucleic acid (or mRNA) vaccines are likely to be the first coronavirus treatment available because they are easier to test and administer than traditional virus-based vaccines. As such, they have become a popular choice among 27 different COVID-19 vaccine candidates currently undergoing human testing worldwide, according to the New York Times coronavirus tracker.